Clinical trial
Comparative Efficacy of Mizoribine With Mycophenolate Mofetil for Living Related Kidney Transplantation Recipients
NCT06114953 is registered in ClinicalTrials.gov with Lee's Pharmaceutical Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Efficacy of Mizoribine With Mycophenolate Mofetil for Living Related Kidney Transplantation Recipients
- Lead sponsor
- Lee's Pharmaceutical Limited
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 1, 2023
- Completion date
- March 1, 2025
- Enrollment
- 152 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
kidney transplant immunosuppression